Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Babic, A. et al. (2017) Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium. Cancer Causes and Control, 28(5), pp. 459-468. (doi:10.1007/s10552-016-0841-3) (PMID:28050675)

Sucheston-Campbell, L. E. et al. (2017) No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers and Prevention, 26(3), pp. 420-424. (doi:10.1158/1055-9965.EPI-16-0631) (PMID:27677730)

Kar, S. P. et al. (2017) Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer, 116(4), pp. 524-535. (doi:10.1038/bjc.2016.426) (PMID:28103614)

Kar, S. P. et al. (2016) Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discovery, 6(9), pp. 1052-1067. (doi:10.1158/2159-8290.CD-15-1227) (PMID:27432226) (PMCID:PMC5010513)

Johnatty, S. E. et al. (2015) Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research, 21(23), pp. 5264-5276. (doi:10.1158/1078-0432.CCR-15-0632) (PMID:26152742) (PMCID:PMC4624261)

Charbonneau, B. et al. (2014) Risk of ovarian cancer and the NF- B pathway: genetic association with IL1A and TNFSF10. Cancer Research, 74(3), pp. 852-861. (doi:10.1158/0008-5472.CAN-13-1051)

This list was generated on Mon Nov 18 18:43:40 2019 GMT.